NCT03852472 Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Status COMPLETED Phase PHASE2
NCT03851263 Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion Status WITHDRAWN Phase PHASE4
NCT03848052 Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Status RECRUITING Phase N/A
NCT03836053 Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03836040 Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03832998 Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Status COMPLETED Phase PHASE3
NCT03829046 The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease Status COMPLETED Phase PHASE4
NCT03828045 A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment Status COMPLETED Phase N/A
NCT03822078 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women Status COMPLETED Phase PHASE1
NCT03818607 A Study Evaluating the Efficacy and Safety of ABP 959 Compared With Eculizumab in Adult Participants With PNH Status COMPLETED Phase PHASE3
NCT03817424 A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Status COMPLETED Phase PHASE1
NCT03815279 A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT03812367 Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid Status WITHDRAWN Phase N/A
NCT03811418 A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer Status WITHDRAWN Phase PHASE3
NCT03809663 A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03802604 Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer Status COMPLETED Phase EARLY_PHASE1
NCT03797261 A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies Status TERMINATED Phase PHASE1